Farhad Peerani - Concepedia

Author

Farhad Peerani

University of Alberta ORCID

Also Known As

F Peerani, F. Peerani, Farhad Peerani, Julian Panes Diaz

106

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Alberta University of Calgary University of California San Diego Lenox Hill Hospital McMaster University

About

Farhad Peerani is an author at University of Alberta specializing in rheumatoid arthritis, immunology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	89
2	Gastroenterology	1	1	89
3	Immunology	1	1	89
4	Inflammation	1	1	89
5	Pharmacotherapy	1	1	89

Farhad Peerani

Publications

882

Citations

H-Index

Page 1

	Year	Citations
The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium Parambir S. Dulai, Siddharth Singh, Xiaoqian Jiang, The American Journal of Gastroenterology	2016	314
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium Neeraj Narula, Farhad Peerani, Joseph Meserve, The American Journal of Gastroenterology	2018	171
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease Parambir S. Dulai, Brigid S. Boland, Siddharth Singh, Gastroenterology	2018	140
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryImmunologyGastroenterologyMaintenance Therapy	2021	89
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium Amanda M. Johnson, Maria Barsky, Waseem Ahmed, The American Journal of Gastroenterology	2022	63
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis Christopher Ma, Remo Panaccione, Yasi Xiao, The American Journal of Gastroenterology	2022	38
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease Farhad Peerani, Makayla Watt, Kathleen P. Ismond, Therapeutic Advances in Gastroenterology	2022	29
Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization Ellina Lytvyak, Reed T. Sutton, Levinus A. Dieleman, Crohn s & Colitis 360	2020	15
Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients Katherine Bedard, Lorian Taylor, Naheed Rajabali, Therapeutic Advances in Gastroenterology	2023	12
Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease Dina Kao, Karen Wong, Humberto Jijon, The American Journal of Gastroenterology	2024	11

Page 1